Page last updated: 2024-11-05

tosufloxacin and Neutropenia

tosufloxacin has been researched along with Neutropenia in 3 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shinohara, A1
Yoshiki, Y1
Masamoto, Y1
Hangaishi, A1
Nannya, Y1
Kurokawa, M1
Haeusler, GM1
Slavin, MA1
Mori, S1
Ohashi, K1
Akiyama, H1
Shoji, H1
Sato, H1
Tanikawa, S1
Sakamaki, H1
Onozawa, Y1

Trials

1 trial available for tosufloxacin and Neutropenia

ArticleYear
Tosulfloxacin versus norfloxacin for prevention of infections in chemotherapy-induced neutropenic patients.
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1994, Volume: 68, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Bacterial Infections; Drug Ev

1994

Other Studies

2 other studies available for tosufloxacin and Neutropenia

ArticleYear
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquin

2013
Fluoroquinolone prophylaxis: worth the cost?
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans

2013